XML 21 R14.htm IDEA: XBRL DOCUMENT
v3.25.3

Stockholders' Equity | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
Stockholders' Equity | No te 6: Stockholders' Equity Common Stock In May 2025, the Company’s board of directors authorized a new share repurchase program (the “2025 Repurchase Program”), which supersedes and replaces all prior repurchase programs. Under the 2025 Repurchase Program, the Company is authorized to repurchase up to 3,000,000 shares of the Company’s Class B common stock in the aggregate through open market and privately negotiated transactions, at such times and in such amounts as the Company deems appropriate. Repurchases may also be made under a Rule 10b5-1 plan, which would permit shares to be repurchased when the Company might otherwise be precluded from doing so under insider trading laws. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, capital availability, and other market conditions. The 2025 Repurchase Program does not have an expiration date and may be expanded, limited, or terminated at any time without prior notice. The Company has made no repurchases under the 2025 Repurchase Program and additionally no repurchases were made under the superseded 2014 Repurchase Program for the three and nine months ended September 30, 2025 and 2024, respectively. Shares repurchased but not yet retired by the Company will be classified as treasury stock on the Consolidated Balance Sheets before retirement. Retirement of treasury stock results in reductions to common stock and additional paid-in capital. Stock-based Compensation Plans The Company grants stock-based awards, including stock options, restricted stock awards ("RSAs"), and restricted stock units ("RSUs"). The Company measures stock-based compensation cost at the grant date based on the fair value of the award and recognizes it as expense over the vesting or service period, as applicable, of the stock-based award using the straight-line method. The Company accounts for forfeitures as they occur. Stock-based compensation expense has been included in the same lines as compensation paid to the same employees in the Consolidated Statements of Operations. Stock-based compensation expense was included in the following operating expense categories:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
(In Thousands) |  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Cost of revenue |  | $ | 4 |  |  | $ | 8 |  |  | $ | 8 |  |  | $ | 14 |
Sales and marketing |  |  | 100 |  |  |  | 41 |  |  |  | 297 |  |  |  | 217 |
Product development |  |  | 70 |  |  |  | 13 |  |  |  | 175 |  |  |  | 35 |
General and administrative |  |  | 746 |  |  |  | 349 |  |  |  | 1,451 |  |  |  | 1,015 |
Total stock-based compensation |  | $ | 920 |  |  | $ | 411 |  |  | $ | 1,931 |  |  | $ | 1,281 |
The Company uses the Black-Scholes option pricing model to estimate the per share fair value of stock option grants with time-based vesting. The Black-Scholes model relies on a number of key assumptions to calculate estimated fair values. For both the three and nine months ended September 30, 2025 and 2024, the expected life of each award granted was determined based on historical experience with similar awards, giving consideration to contractual terms, anticipated exercise patterns, and vesting schedules. Expected volatility is based on historical volatility levels of the Company’s Class B common stock. The risk-free interest rate is based on the implied yield currently available on U.S. Treasury issues with terms approximately equal to the expected life of the option. The Company uses an expected annual dividend yield in consideration of the Company’s common stock dividend payments, which we consider to be zero. The following assumptions were used in determining the fair value of time-vested stock option grants for the periods indicated:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Expected life (in years) |  | 4.00 |  | 4.00 - 6.25 |  | 4.00 |  | 4.00 - 6.25
Risk-free interest rate |  | 3.93% |  | 3.93% - 4.08% |  | 3.65% - 4.32% |  | 3.93% - 4.43%
Expected volatility |  | 59% |  | 57% - 59% |  | 57% - 59% |  | 57% - 64%
As of September 30, 2025, there were $1.6 million of unrecognized compensation costs related to stock options. These costs are expected to be recognized over the weighted average periods of 2.30 years. St ock option activity during the period was as follows:
| Options (In Thousands) |  |  | Weighted average exercise price of options |  |  | Weighted average remaining contractual term (in years) |
Balance at December 31, 2024 |  | 7,039 |  |  | $ | 1.91 |  |  |  | 7.57 |
Options granted |  | 553 |  |  |  | 1.94 |  |  |  |
Options forfeited |  | (297 | ) |  |  | 1.54 |  |  |  |
Options expired |  | (168 | ) |  |  | 3.78 |  |  |  |
Options exercised |  | (217 | ) |  |  | 1.39 |  |  |  |
Balance at September 30, 2025 |  | 6,910 |  |  | $ | 1.90 |  |  |  | 7.50 |
As of September 30, 2025, there was $0.4 million of unrecognized compensation costs related to restricted stock. These costs are expected to be recognized over the weighted average period of 0.62 years. RSA and RSU activity during the period was as follows:
|  | Shares/ Units (In Thousands) |  |  | Weighted Average Grant Date Fair Value |
Unvested at December 31, 2024 |  |  | 406 |  |  | $ | 2.04 |
Granted |  |  | 447 |  |  |  | 1.75 |
Vested |  |  | (270 | ) |  |  | 1.90 |
Forfeited |  |  | (22 | ) |  |  | 2.86 |
Unvested at September 30, 2025 |  |  | 561 |  |  | $ | 1.87 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration